
Researchers found that a genetic mutation causing Verheij syndrome disrupts RNA splicing, which specifically impairs vitamin B12-dependent metabolic pathways. In C. elegans worms, supplementing with the vitamin restored normal growth and reversed developmental abnormalities.
This suggests that metabolic corrections might treat rare genetic disorders previously thought to require complex genetic interventions. However, human clinical trials are still needed to confirm if this simple supplement works for patients.
more: https://www.sciencedaily.com/releases/2026/11/261115085552.htm
my other side: ivo.blogspot.com
Leave a Reply